国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
运用欧洲药学监护联盟分类系统处理药物相关问题促进药学监护发展
Pharmaceutical Care Network Europe Classification Used to Treat Drug related Problems to Promote the Development of Pharmaceutical Care
  
DOI:
中文关键词:  欧洲药学监护联盟  药物相关问题  药物相关问题分类系统  临床药师
英文关键词:Pharmaceutical Care Network Europe  Drug related problems  DRPs Classification system  Clinical pharmacists
基金项目:
作者单位
肖坚1,2 黄娅敏1,2 刘可可1,2 黄行行1,2 杨永榆3 孙树森1,2,4 1.中南大学湘雅医院药学部长沙 410008 2.中南大学湘雅医院国家老年疾病临床医学研究中心-老年合理用药与安全用药研究室3.广西省北海市第二人民医院4.美国西新英格兰大学药学与健康科学学院 
摘要点击次数: 723
全文下载次数: 447
中文摘要:
      摘 要药物相关问题(DRPs)的识别、预防和解决,是药学监护的核心过程,这些DRPs包括但不限于实际和潜在的药品不良反应和药物相互作用。因此,记录DRPs的潜在原因并对DRPs进行分类是药学实践发展的需要,也是药学研究的重要内容。欧洲药学监护联盟(PCNE)于1999年提出的PCNE分类系统经不断验证更新,已经在全球范围得以应用。对临床药师而言,PCNE分类系统能成为一个相对全面、规范、清晰的划分标准,推动药学监护朝有效负责的方向发展。另一方面,PCNE分类系统也能全面记录临床药师工作流程,可作为临床药师日常工作量化指标,提高工作效率和积极性。
英文摘要:
      ABSTRACTThe identification, prevention and resolution of drug related problems (DRPs) is the core processes of pharmaceutical care. DRPs include, but are not limited to, actual and potential adverse drug reactions such as side effects or drug interactions. Therefore, recording the potential causes of DRPs and classifying DRPs is a requirement for the development of pharmaceutical practice. It's also an important part of pharmaceutical research. The PCNE classification system for DRPs proposed by the Pharmaceutical Care Network Europe (PCNE) in 1999 has been continuously updated. It is widely applied all over the world now. For clinical pharmacists, the PCNE classification system can become a relatively comprehensive, standardized and clear standard to promote the development of pharmaceutical care in an effective and responsible direction. On the other hand, the PCNE classification system can also comprehensively record the clinical pharmacist’s workflow. Furthermore, it can even become a quantitative indicator of the daily work of clinical pharmacists and ultimately improve their work efficiency and enthusiasm.
查看全文  查看/发表评论  下载PDF阅读器
关闭